Quadrant Capital Group’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-186
Closed -$4.56K 2644
2026
Q1
$4.56K Buy
+186
New +$4.4K ﹤0.01% 2376
2025
Q4
Sell
-18
Closed -$511 2800
2025
Q3
$511 Buy
+18
New +$488 ﹤0.01% 2614
2025
Q2
Sell
-3,383
Closed -$105K 2684
2025
Q1
$105K Buy
3,383
+2,601
+333% +$86.7K ﹤0.01% 1522
2024
Q4
$24.7K Sell
782
-180
-19% -$8.55K ﹤0.01% 1788
2024
Q3
$55.7K Hold
962
﹤0.01% 1388
2024
Q2
$39K Buy
962
+58
+6% +$2.3K ﹤0.01% 1531
2024
Q1
$38K Buy
904
+59
+7% +$2.3K ﹤0.01% 1540
2023
Q4
$32.4K Sell
845
-166
-16% -$5.53K ﹤0.01% 1599
2023
Q3
$31.2K Buy
1,011
+89
+10% +$3.07K ﹤0.01% 1497
2023
Q2
$29.1K Sell
922
-512
-36% -$17.6K ﹤0.01% 1525
2023
Q1
$52.3K Buy
1,434
+672
+88% +$23.5K 0.01% 1213
2022
Q4
$22.5K Buy
762
+566
+289% +$18.2K ﹤0.01% 1605
2022
Q3
$8K Buy
196
+187
+2,078% +$8.56K ﹤0.01% 1991
2022
Q2
$0 Buy
+9
New +$342 ﹤0.01% 2776
2022
Q1
Sell
-2
Closed 2719
2021
Q4
$0 Hold
2
﹤0.01% 2723
2021
Q3
$0 Hold
2
﹤0.01% 2681
2021
Q2
$0 Buy
+2
New +$74 ﹤0.01% 2599

Other funds holding ASTH

Quadrant Capital Group's ASTH Position: Q2 2026 in Review

Quadrant Capital Group sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 186 shares — an estimated $4.56K sold.

Quadrant Capital Group first reported a position in ASTH in Q2 2021 and held it in 17 quarters. The position peaked at $105K in Q1 2025. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Quadrant Capital Group reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 186 Astrana Health shares in Q2 2026, an estimated $4.56K.
  • Quadrant Capital Group first reported a position in Astrana Health in Q2 2021 and held it in 17 quarters.
  • Quadrant Capital Group's Astrana Health position peaked at $105K in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.